These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16178119)

  • 1. Wet age-related macular degeneration.
    Melnikova I
    Nat Rev Drug Discov; 2005 Sep; 4(9):711-2. PubMed ID: 16178119
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthaproblem. Wet age-related macular degeneration.
    Podbielski DW; Noble J
    Can Fam Physician; 2008 Oct; 54(10):1395-8. PubMed ID: 18854465
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-related macular degeneration: new treatments show promise.
    DuBosar R
    J Ophthalmic Nurs Technol; 1999; 18(2):60-4. PubMed ID: 10409997
    [No Abstract]   [Full Text] [Related]  

  • 4. Ranibizumab for neovascular age-related macular degeneration.
    Liew G; Mitchell P
    N Engl J Med; 2007 Feb; 356(7):747-8; author reply 749-50. PubMed ID: 17301310
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unspecific effects of certain siRNA molecules used in the treatment of age related macular degeneration].
    Ebbesen M; Bek T; Pedersen FS; Jensen TG
    Ugeskr Laeger; 2010 Sep; 172(36):2457-9. PubMed ID: 20825735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes.
    Raja MS; Saldana M; Goldsmith C; Burton BJ
    Br J Ophthalmol; 2010 Nov; 94(11):1543-5. PubMed ID: 20516142
    [No Abstract]   [Full Text] [Related]  

  • 7. Ranibizumab treatment in patients with neovascular age-related macular degeneration and very low vision.
    Sørensen TL; Kemp H
    Acta Ophthalmol; 2011 Feb; 89(1):e97. PubMed ID: 20384603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Age-related macular degeneration; therapeutic options].
    La Heij EC; Liem AT; Hendrikse F
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab for neovascular age-related macular degeneration.
    Gillies MC; Wong TY
    N Engl J Med; 2007 Feb; 356(7):748-9; author reply 749-50. PubMed ID: 17310523
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-related macular degeneration.
    El-Amir AN; Sagoo MS; da Cruz L
    Br J Hosp Med (Lond); 2005 Dec; 66(12):677-81. PubMed ID: 16417106
    [No Abstract]   [Full Text] [Related]  

  • 11. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
    Carneiro AM; Silva RM; Veludo MJ; Barbosa A; Ruiz-Moreno JM; Falcão MS; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2011; 225(2):81-8. PubMed ID: 20881442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration.
    Sweeney K
    Drug Discov Today; 2005 Oct; 10(20):1346-8. PubMed ID: 16253870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic options in age-related exudative macular degeneration].
    Stanca HT
    Oftalmologia; 2007; 51(1):7-11. PubMed ID: 17605263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing in wet age-related macular degeneration.
    Arjamaa O
    Lancet; 2006 Aug; 368(9536):630-1. PubMed ID: 16920453
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ziemssen F; Heiduschka P; Schraermeyer U;
    Retina; 2007 Oct; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
    [No Abstract]   [Full Text] [Related]  

  • 17. Age-related macular degeneration: answers to some common questions.
    Smith SC; Lamb P; Liu J
    Insight; 2005; 30(3):17-21; quiz 22-3. PubMed ID: 16350357
    [No Abstract]   [Full Text] [Related]  

  • 18. Age related macular degeneration.
    Chakravarthy U; Evans J; Rosenfeld PJ
    BMJ; 2010 Feb; 340():c981. PubMed ID: 20189972
    [No Abstract]   [Full Text] [Related]  

  • 19. [RNA interference, anti-integrins and retinol binders. New strategies to control blindness in the elderly].
    Arand M
    MMW Fortschr Med; 2008 Oct; 150(44):18. PubMed ID: 19024488
    [No Abstract]   [Full Text] [Related]  

  • 20. Age-related macular degeneration.
    Ong BB; Ah-Fat FG
    Br J Hosp Med (Lond); 2016 Feb; 77(2):C18-21. PubMed ID: 26875813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.